These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15971309)

  • 1. Clinical complementarities between proton and carbon therapies.
    Mazeron JJ; Noel G; Feuvret L; Calugaru V; Racadot S
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S50-2. PubMed ID: 15971309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiobiological rationale and patient selection for high-LET radiation in cancer therapy.
    Wambersie A; Hendry J; Gueulette J; Gahbauer R; Pötter R; Grégoire V
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S1-14. PubMed ID: 15971301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of clinical experiences on carbon ion radiotherapy at NIRS.
    Tsujii H; Mizoe JE; Kamada T; Baba M; Kato S; Kato H; Tsuji H; Yamada S; Yasuda S; Ohno T; Yanagi T; Hasegawa A; Sugawara T; Ezawa H; Kandatsu S; Yoshikawa K; Kishimoto R; Miyamoto T
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S41-9. PubMed ID: 15971308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast neutron therapy at the end of 1988--a survey of the clinical data.
    Wambersie A
    Strahlenther Onkol; 1990 Jan; 166(1):52-60. PubMed ID: 2405533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there any future for high-LET radiation?
    Wambersie A
    Strahlenther Onkol; 1989 Apr; 165(4):348-56. PubMed ID: 2540543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A challenge for high-precision radiation therapy: the case for hadrons.
    Wambersie A; Auberger T; Gahbauer RA; Jones DT; Pötter R
    Strahlenther Onkol; 1999 Jun; 175 Suppl 2():122-8. PubMed ID: 10394420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present status of fast neutron therapy in Asian countries.
    Tsunemoto H; Yoo SY
    Bull Cancer Radiother; 1996; 83 Suppl():93s-100s. PubMed ID: 8949758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant salivary gland tumours: can fast neutron therapy results point the way to carbon ion therapy?
    Stannard C; Vernimmen F; Carrara H; Jones D; Fredericks S; Hille J; de Kock E
    Radiother Oncol; 2013 Nov; 109(2):262-8. PubMed ID: 24044797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects for the application of fast neutrons in cancer therapy. Radiobiological bases and survey of the clinical data.
    Wambersie A; Bewley DK; Lalanne CM
    Bull Cancer; 1986; 73(5):546-61. PubMed ID: 3535937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients.
    Suit H; DeLaney T; Goldberg S; Paganetti H; Clasie B; Gerweck L; Niemierko A; Hall E; Flanz J; Hallman J; Trofimov A
    Radiother Oncol; 2010 Apr; 95(1):3-22. PubMed ID: 20185186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrons applications in cancer treatment and in specific diagnostics.
    Shahri KK; Motavalli LR; Hakimabad HM
    Hell J Nucl Med; 2011; 14(2):110-3. PubMed ID: 21761010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of the clinical results of fast neutron therapy.
    Schmitt G; Wambersie A
    Radiother Oncol; 1990 Jan; 17(1):47-56. PubMed ID: 2108475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Monte Carlo study for the calculation of the average linear energy transfer (LET) distributions for a clinical proton beam line and a radiobiological carbon ion beam line.
    Romano F; Cirrone GA; Cuttone G; Rosa FD; Mazzaglia SE; Petrovic I; Fira AR; Varisano A
    Phys Med Biol; 2014 Jun; 59(12):2863-82. PubMed ID: 24828462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast neutron radiation for inoperable and recurrent salivary gland cancers.
    Koh WJ; Laramore G; Griffin T; Russell K; Griffin B; Parker R; Davis L; Pajak TF
    Am J Clin Oncol; 1989 Aug; 12(4):316-9. PubMed ID: 2667321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal crypt regeneration in mice: a biological system for quality assurance in non-conventional radiation therapy.
    Gueulette J; Octave-Prignot M; De Costera BM; Wambersie A; Grégoire V
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S148-54. PubMed ID: 15971332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with charged particles beams: hadrontherapy part I: physical basis and clinical experience of treatment with protons].
    Noël G; Feuvret L; Ferrand R; Mazeron JJ
    Cancer Radiother; 2003 Oct; 7(5):321-39. PubMed ID: 14522354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fast neutron radiotherapy: for equal or for better?
    Broerse JJ; Battermann JJ
    Med Phys; 1981; 8(6):751-60. PubMed ID: 7322073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of clinical results of fast neutron therapy in the USA.
    Peters LJ; Maor MH; Laramore GE; Griffin TW; Hendrickson FR
    Strahlentherapie; 1985 Dec; 161(12):731-8. PubMed ID: 4082208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiotherapy for sarcoma: hadrontherapy, for whom and what for?].
    Pommier P; Sunyach MP; Hu Y; Amsalem E; Claude L; Moncort-Boulch D; Toutenu P; Balosso J
    Bull Cancer; 2010 Jun; 97(6):657-72. PubMed ID: 20547480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review and evolution of clinical results in the EORTC Heavy-Particle Therapy Group.
    Wambersie A; Battermann JJ
    Strahlentherapie; 1985 Dec; 161(12):746-55. PubMed ID: 3909530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.